Brett Guthrie U.S. House of Representatives from Kentucky's 2nd district | Official U.S. House Headshot
Brett Guthrie U.S. House of Representatives from Kentucky's 2nd district | Official U.S. House Headshot
WASHINGTON, D.C. - Congressman Brett Guthrie (KY-02), Chairman of the Health Subcommittee of the House Energy & Commerce Committee, released a statement following the Biden-Harris administration's release of the first round of Centers for Medicare & Medicaid Services (CMS) negotiated drug prices.
“Don’t be fooled by Biden and Harris’ talking points today, seniors are not better off from today’s announcement. It’s important to know that their far-left government drug price controls regime has already resulted in significant increases in monthly premiums for seniors’ prescription drug benefits, less access to future life-saving cures, and most likely less access to the life-saving therapies they currently take, which means there’s no guarantee seniors will even see these savings. Addressing the high costs of prescription drugs is an essential priority for Congress, but cannot be done in a way that crushes innovation and creates more instability for seniors on fixed incomes,” said Congressman Guthrie.
###
Alerts Sign-up